VIP provides cellular protection through a specific splice variant of the PACAP receptor: A new neuroprotection target
- 1 November 2006
- Vol. 27 (11) , 2867-2876
- https://doi.org/10.1016/j.peptides.2006.06.007
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Subcellular localization and secretion of activity-dependent neuroprotective protein in astrocytesNeuron Glia Biology, 2004
- Novel Alternatively Spliced Exon in the Extracellular Ligand-binding Domain of the Pituitary Adenylate Cyclase-activating Polypeptide (PACAP) Type 1 Receptor (PAC1R) Selectively Increases Ligand Affinity and Alters Signal Transduction Coupling during SpermatogenesisJournal of Biological Chemistry, 2001
- Alternative Splicing in the N-terminal Extracellular Domain of the Pituitary Adenylate Cyclase-activating Polypeptide (PACAP) Receptor Modulates Receptor Selectivity and Relative Potencies of PACAP-27 and PACAP-38 in Phospholipase C ActivationPublished by Elsevier ,1996
- Two receptors for vasoactive intestinal polypeptide with similar specificity and complementary distributionsEndocrinology, 1994
- Multiple receptors for PACAP and VIPTrends in Pharmacological Sciences, 1994
- Differential signal transduction by five splice variants of the PACAP receptorNature, 1993
- 38‐Amino acid form of pituitary adenylate cyclase activating peptide induces process outgrowth in human neuroblastoma cellsJournal of Neuroscience Research, 1993
- Vasoactive intestinal peptide: A neurotrophic releasing agent and an astroglial mitogenJournal of Neuroscience Research, 1990
- Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cellsBiochemical and Biophysical Research Communications, 1989
- Nonneuronal cells mediate neurotrophic action of vasoactive intestinal peptide.The Journal of cell biology, 1987